Literature DB >> 21711110

microRNA-143 protects cells from DNA damage-induced killing by downregulating FHIT expression.

Yu-Xiang Lin1, Fang Yu, Ning Gao, Ji-Po Sheng, Jun-Zhi Qiu, Bao-Cheng Hu.   

Abstract

MicroRNAs (miRNAs) are posttranscriptional modulators of gene expression and play an important role in many developmental processes. Recent studies suggest roles of miRNAs in carcinogenesis. Fragile histidine triad (FHIT) gene deletion, methylation, and reduced Fhit protein expression occur in about 70% of human epithelial tumors and are clearly associated with tumor progression. Although it has been previously reported that Fhit(-/-)cells exhibit more resistance to multi-DNA damage inducers, including ionizing radiation, it remains unclear how miRNAs targeting FHIT in DNA damage response play the role. This study reports that miR-143 directly targets FHIT and that overexpression of miR-143 results in significant G2-phase arrest and protects cells from DNA damage-induced killing. These results indicate an association of FHIT gene inactivation with increased survival after DNA damage and also provide useful information for miRNA-based drug development in two directions: protect cells from DNA damage-induced killing and sensitize cells to radiation therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21711110     DOI: 10.1089/cbr.2010.0914

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  8 in total

1.  MicroRNA-376a sensitizes cells following DNA damage by downregulating MEPE expression.

Authors:  Jipo Sheng; Wei Luo; Fang Yu; Ning Gao; Baocheng Hu
Journal:  Cancer Biother Radiopharm       Date:  2013-04-09       Impact factor: 3.099

Review 2.  microRNA expression and biogenesis in cellular response to ionizing radiation.

Authors:  Aihong Mao; Yang Liu; Hong Zhang; Cuixia Di; Chao Sun
Journal:  DNA Cell Biol       Date:  2014-06-06       Impact factor: 3.311

3.  Aberrant crypt focus and fragile histidine triad protein in sporadic colorectal carcinoma.

Authors:  Kim Vaiphei; Aruna Rangan; Rajinder Singh
Journal:  World J Gastrointest Oncol       Date:  2012-12-15

Review 4.  MicroRNAs involved in chemo- and radioresistance of high-grade gliomas.

Authors:  Andrej Besse; Jiri Sana; Pavel Fadrus; Ondrej Slaby
Journal:  Tumour Biol       Date:  2013-04-09

5.  DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.

Authors:  Hon-Yi Lin; Shih-Kai Hung; Moon-Sing Lee; Wen-Yen Chiou; Tze-Ta Huang; Chih-En Tseng; Liang-Yu Shih; Ru-Inn Lin; Jora M J Lin; Yi-Hui Lai; Chia-Bin Chang; Feng-Chun Hsu; Liang-Cheng Chen; Shiang-Jiun Tsai; Yu-Chieh Su; Szu-Chi Li; Hung-Chih Lai; Wen-Lin Hsu; Dai-Wei Liu; Chien-Kuo Tai; Shu-Fen Wu; Michael W Y Chan
Journal:  Oncotarget       Date:  2015-01-20

Review 6.  MicroRNA expression and its association with DNA repair in preimplantation embryos.

Authors:  Pinar Tulay; Sioban B Sengupta
Journal:  J Reprod Dev       Date:  2016-02-05       Impact factor: 2.214

7.  Serum miR-143 levels predict the pathological response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.

Authors:  Yukiharu Hiyoshi; Takashi Akiyoshi; Ramu Inoue; Keiko Murofushi; Noriko Yamamoto; Yosuke Fukunaga; Masashi Ueno; Hideo Baba; Seiichi Mori; Toshiharu Yamaguchi
Journal:  Oncotarget       Date:  2017-03-31

8.  Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases.

Authors:  Marcia Bellon; Izabela Bialuk; Veronica Galli; Xue-Tao Bai; Lourdes Farre; Achilea Bittencourt; Ambroise Marçais; Michael N Petrus; Lee Ratner; Thomas A Waldmann; Vahid Asnafi; Antoine Gessain; Masao Matsuoka; Genoveffa Franchini; Olivier Hermine; Toshiki Watanabe; Christophe Nicot
Journal:  Mol Cancer       Date:  2021-06-06       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.